Legal & General Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Sell |
95,968
-15,819
| -14% | -$352K | ﹤0.01% | 1877 |
|
|
2025
Q4 | $2.89M | Sell |
111,787
-5,682
| -5% | -$135K | ﹤0.01% | 1827 |
|
|
2025
Q3 | $3.03M | Sell |
117,469
-11,703
| -9% | -$287K | ﹤0.01% | 1803 |
|
|
2025
Q2 | $3.09M | Buy |
129,172
+7,045
| +6% | +$178K | ﹤0.01% | 1788 |
|
|
2025
Q1 | $3.03M | Sell |
122,127
-3,722
| -3% | -$89.1K | ﹤0.01% | 1759 |
|
|
2024
Q4 | $2.37M | Buy |
125,849
+2,150
| +2% | +$37.7K | ﹤0.01% | 1907 |
|
|
2024
Q3 | $1.86M | Sell |
123,699
-2,333
| -2% | -$39.9K | ﹤0.01% | 2005 |
|
|
2024
Q2 | $3.61M | Sell |
126,032
-2,408
| -2% | -$68.5K | ﹤0.01% | 1690 |
|
|
2024
Q1 | $3.75M | Buy |
128,440
+171
| +0.1% | +$5.25K | ﹤0.01% | 1655 |
|
|
2023
Q4 | $4.33M | Sell |
128,269
-608
| -0.5% | -$17.8K | ﹤0.01% | 1590 |
|
|
2023
Q3 | $3.95M | Sell |
128,877
-3,088
| -2% | -$111K | ﹤0.01% | 1565 |
|
|
2023
Q2 | $5.29M | Sell |
131,965
-625
| -0.5% | -$25.8K | ﹤0.01% | 1433 |
|
|
2023
Q1 | $5.41M | Sell |
132,590
-193
| -0.1% | -$7.68K | ﹤0.01% | 1372 |
|
|
2022
Q4 | $5.13M | Buy |
132,783
+1,103
| +0.8% | +$53.7K | ﹤0.01% | 1388 |
|
|
2022
Q3 | $7M | Sell |
131,680
-161
| -0.1% | -$8.95K | ﹤0.01% | 1203 |
|
|
2022
Q2 | $7.69M | Buy |
131,841
+1,310
| +1% | +$85.8K | ﹤0.01% | 1209 |
|
|
2022
Q1 | $9.96M | Buy |
130,531
+3,426
| +3% | +$228K | ﹤0.01% | 1163 |
|
|
2021
Q4 | $7.65M | Buy |
127,105
+4,120
| +3% | +$227K | ﹤0.01% | 1350 |
|
|
2021
Q3 | $6.89M | Buy |
122,985
+9,690
| +9% | +$558K | ﹤0.01% | 1368 |
|
|
2021
Q2 | $6.88M | Sell |
113,295
-29,008
| -20% | -$1.84M | ﹤0.01% | 1374 |
|
|
2021
Q1 | $9.97M | Buy |
142,303
+4,654
| +3% | +$332K | ﹤0.01% | 1201 |
|
|
2020
Q4 | $8.24M | Buy |
137,649
+1,241
| +0.9% | +$72.7K | ﹤0.01% | 1209 |
|
|
2020
Q3 | $8.2M | Buy |
136,408
+1,987
| +1% | +$115K | ﹤0.01% | 1106 |
|
|
2020
Q2 | $7.05M | Buy |
134,421
+10,380
| +8% | +$434K | ﹤0.01% | 1147 |
|
|
2020
Q1 | $4.16M | Buy |
124,041
+436
| +0.4% | +$18.1K | ﹤0.01% | 1235 |
|
|
2019
Q4 | $5.6M | Buy |
123,605
+22,359
| +22% | +$950K | ﹤0.01% | 1308 |
|
|
2019
Q3 | $3.85M | Buy |
101,246
+83,983
| +486% | +$3.35M | ﹤0.01% | 1424 |
|
|
2019
Q2 | $751K | Buy |
17,263
+410
| +2% | +$17.4K | ﹤0.01% | 2047 |
|
|
2019
Q1 | $642K | Buy |
16,853
+201
| +1% | +$7.84K | ﹤0.01% | 2103 |
|
|
2018
Q4 | $717K | Buy |
16,652
+1,129
| +7% | +$52.7K | ﹤0.01% | 2010 |
|
|
2018
Q3 | $763K | Buy |
15,523
+29
| +0.2% | +$1.25K | ﹤0.01% | 2027 |
|
|
2018
Q2 | $496K | Sell |
15,494
-1,071
| -6% | -$37K | ﹤0.01% | 2110 |
|
|
2018
Q1 | $516K | Sell |
16,565
-2,656
| -14% | -$94.6K | ﹤0.01% | 2109 |
|
|
2017
Q4 | $877K | Sell |
19,221
-441
| -2% | -$17.5K | ﹤0.01% | 1932 |
|
|
2017
Q3 | $742K | Buy |
19,662
+6,677
| +51% | +$269K | ﹤0.01% | 1979 |
|
|
2017
Q2 | $620K | Buy |
12,985
+653
| +5% | +$30.3K | ﹤0.01% | 1994 |
|
|
2017
Q1 | $563K | Sell |
12,332
-171
| -1% | -$7.39K | ﹤0.01% | 2005 |
|
|
2016
Q4 | $401K | Buy |
12,503
+3,762
| +43% | +$126K | ﹤0.01% | 2036 |
|
|
2016
Q3 | $293K | Sell |
8,741
-244
| -3% | -$9.56K | ﹤0.01% | 1929 |
|
|
2016
Q2 | $322K | Buy |
8,985
+1,270
| +16% | +$62.4K | ﹤0.01% | 1574 |
|
|
2016
Q1 | $403K | Buy |
7,715
+740
| +11% | +$43.3K | ﹤0.01% | 1410 |
|
|
2015
Q4 | $539K | Hold |
6,975
| – | – | ﹤0.01% | 1304 |
|
|
2015
Q3 | $289K | Buy |
6,975
+363
| +5% | +$22.2K | ﹤0.01% | 1514 |
|
|
2015
Q2 | $459K | Buy |
6,612
+312
| +5% | +$24.6K | ﹤0.01% | 1345 |
|
|
2015
Q1 | $568K | Buy |
6,300
+1,124
| +22% | +$114K | ﹤0.01% | 1253 |
|
|
2014
Q4 | $474K | Sell |
5,176
-109
| -2% | -$10.3K | ﹤0.01% | 1258 |
|
|
2014
Q3 | $521K | Buy |
+5,285
| New | +$514K | ﹤0.01% | 1193 |
|
Other funds holding PCRX
DPCM
VPM
VCM
